Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β-negative cognitively normal individuals.


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
01 2021
Historique:
received: 06 05 2020
revised: 10 08 2020
accepted: 15 09 2020
pubmed: 2 11 2020
medline: 2 9 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

We examined whether mesial temporal (Me) tau relates to cognitive performance in 47 amyloid-β (Aβ)-negative, cognitively normal older adults (>60 years old). Me-tau was measured using [

Identifiants

pubmed: 33130455
pii: S0197-4580(20)30294-3
doi: 10.1016/j.neurobiolaging.2020.09.017
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Carbolines 0
Radiopharmaceuticals 0
tau Proteins 0
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole J09QS3Z3WB

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-48

Subventions

Organisme : NIA NIH HHS
ID : R01 AG029672
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Colin Groot (C)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. Electronic address: c.groot3@amsterdamumc.nl.

Vincent Doré (V)

CSIRO Health and Biosecurity, Parkville, Victoria, Australia; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Victoria, Australia.

Joanne Robertson (J)

The Florey Institute, The University of Melbourne, Parkville, Victoria, Australia.

Samantha C Burnham (SC)

CSIRO Health and Biosecurity, Parkville, Victoria, Australia; Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.

Greg Savage (G)

Department of Psychology, Macquarie University, North Ryde, New South Wales, Australia.

Rik Ossenkoppele (R)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Clinical Memory Research Unit, Lund University, P663+Q9, Lund, Sweden.

Christopher C Rowe (CC)

Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Victoria, Australia.

Victor L Villemagne (VL)

Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH